When was Alcance Genomics founded?

Alcance Genomics was founded in 2025.

Where is Alcance Genomics located?

Alcance Genomics is headquartered in San Diego, United States.

Where does Alcance Genomics rank among its competitors?

Alcance Genomics ranks 1378th amongst 1550 active competitors, of which 28 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Verantos, which secured $5.69M in Feb, 2025.

Who are the top competitors of Alcance Genomics?

Alcance Genomics' top competitors include IntegriChain, CMIC HOLDINGS and Prescient Healthcare Group. Among them, Verantos secured the most recent funding round in February, 2025.

Alcance Genomics - 2026 Company Profile & Competitors

Company Details

Provider of consulting services for genomics program development and implementation. Services include commercial strategy, clinical workflow optimization, and technical guidance for integrating genomic applications into research and clinical environments. Expertise covers regulatory navigation, market assessment, financial modeling, and protocol development for precision medicine initiatives. Support extends to program design and the creation of systems for genetic testing and patient engagement.

Key Metrics

Founded Year

2025

Location

San Diego, United States

Stage

Unfunded

Ranked

1378^th among 1550 active competitors

Similar Companies

IntegriChain & 1809 more

View Alcance Genomics' full profile

Alcance Genomics has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Alcance Genomics include IntegriChain, CMIC HOLDINGS and Prescient Healthcare Group. Here is the list of Top 10 competitors of Alcance Genomics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	IntegriChain 2005, Philadelphia (United States), Acquired	Pharma commercialization solutions: data, consulting, and technology for market access	$2M	Activate Venture Partners, SaaS Capital & 4 others	65/100
2nd	CMIC HOLDINGS 1985, Tokyo (Japan), Acquired	Contract service provider for biopharma companies	-	-	61/100
3rd	Prescient Healthcare Group 2007, London (United Kingdom), Series B	Consulting services for product strategy and decision support	$12.7M	Baird Capital, Intertrust & 8 others	59/100
4th	Clinigen 2010, Burton-on-trent (United Kingdom), Acquired	Services in clinical trials & medicine supply	-	RBS Group, Santander Bank & 3 others	58/100
5th	Diaceutics 2005, Belfast (United Kingdom), Public	Analytics based integrator for precision medicine	-	Herald Investment Management, SVB & 4 others	57/100
6th	Fabtech 2002, Mumbai (India), Public	Provider of instruments for biotech, pharmaceutical, and biomedical industries	$175K	Acaciaa International TR LLC, T Square Enterprises ... & 9 others	56/100
7th	Sequence 2002, Morrisville (United States), Acquired	Consulting services provider	-	-	52/100
8th	Oxford PharmaGenesis 1998, Oxford (United Kingdom), Acquired	Provider of medical affairs, marketing, communication, consultancy, and other services for healthcare sector	-	-	52/100
9th	Enavate Sciences 2022, United States, Series D	Provider of consulting services to improve drug discovery & development and market assessment services	$300M	Patient Square Capital, Elevage Medical Technologies ... Read more	51/100
10th	Verantos 2009, Menlo Park (United States), Funding Raised	Provider of data validation and regulatory services to biopharma sector	-	NIH, National Science Foundation & 1 others	50/100
1378th	Alcance Genomics 2025, San Diego (United States), Unfunded	Provider of consulting services for genomics program development and implementation	-	-	16/100